Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bristol-Myers Squibb Co (BMY) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance

Bristol-Myers Squibb CoTrade
First Trust NASDAQ 100 Technology Index FundTrade

Price performance (Past 24H)

Key statistics

Bristol-Myers Squibb Co vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? Bristol-Myers Squibb Co trades at $63.68 (market cap $129.94B), while First Trust NASDAQ 100 Technology Index Fund trades at $321.3. The key difference: Bristol-Myers Squibb Co pays a 3.96% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals.

BMYQTEC
Market Cap
$129.94B
Sector
HealthBroad Market / Factor
52-Week High
$65.89$335.74
52-Week Low
$42.60$207.03
Enterprise Value
$163.92B
Dividend Yield
3.96%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bristol-Myers Squibb Co

Bristol Myers Squibb (BMY) trades at $64.84, up 0.19% today, with a bullish technical signal from moving averages and strong fundamental health evidenced by a 14.01 P/E ratio and 18.87% net income margin. Recent earnings beats and a $2.3 billion manufacturing investment in Houston highlight operational strength, while analyst consensus is mixed with a $68.56 price target.

The outlook is positive due to earnings momentum and strategic investments, but risks include patent expirations and high debt levels. Wall Street sentiment is cautiously optimistic, with institutional buying supporting the stock's potential for moderate upside from current levels.

First Trust NASDAQ 100 Technology Index Fund

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Read more on BMY

About First Trust NASDAQ 100 Technology Index Fund

QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.

Read more on QTEC